Sponsor
I.M. Sechenov First Moscow State Medical University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name I.M. Sechenov First Moscow State Medical University appears in 34 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
34 shownPatient-Reported Health Status Assessment Using the KCCQ for Early Detection of Heart Failure WorseningNCT07552142 · lead sponsor · 2025-10-01
RECRUITINGBreath Mass Spectrometry in Metabolic Syndrome and Metabolically Healthy ObesityNCT07330297 · lead sponsor · 2024-09-19
RECRUITINGRifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection FractionNCT06652087 · lead sponsor · 2024-09-02
RECRUITINGMetabolomics in the Diagnosis and Treatment of Asthma in ChildrenNCT07280364 · lead sponsor · 2024-03-13
RECRUITINGActive Surveillance for Low Risk Prostate CancerNCT04146077 · lead sponsor · 2019-10-01
RECRUITINGScreening for Pulmonary Embolism Using Single-channel ElectrocardiogramNCT07412418 · lead sponsor · 2026-05-01
NOT_YET_RECRUITINGScreening for Cardiac and Cardiac-associated Pathology Using Single-channel ElectrocardiogramNCT07396792 · lead sponsor · 2026-04-01
NOT_YET_RECRUITINGStaging Heart Failure With Preserved Ejection FractionNCT06931015 · lead sponsor · 2025-04-20
NOT_YET_RECRUITINGRemote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGenceNCT06644339 · lead sponsor · 2024-10-15
NOT_YET_RECRUITINGTreatment Hypertension to Recommended Levels in Old PatientsNCT06865846 · lead sponsor · 2024-04-01
ENROLLING_BY_INVITATIONContriBution of Digital RemOte MoniToring to IMPROVing The Effectiveness of Treatment in Patients With Chronic Heart Failure With Low Ejection FractionNCT06304753 · lead sponsor · 2023-10-27
COMPLETEDClinical and Prognostic Significance of Periodontitis in Patients With Arterial HypertensionNCT07593768 · lead sponsor · 2023-10-10
ACTIVE_NOT_RECRUITINGVExUS in Patients With Acute Heart FailureNCT06397404 · lead sponsor · 2023-05-18
COMPLETEDNon-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction PlanningNCT06061835 · lead sponsor · 2023-05-06
UNKNOWNBreath Analysis and Arterial Stiffness in Patients With Respiratory DiseasesNCT05727852 · lead sponsor · 2023-01-30
ENROLLING_BY_INVITATIONColchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection FractionNCT05637398 · lead sponsor · 2022-12-15
COMPLETEDIntermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.NCT05379608 · lead sponsor · 2021-12-10
COMPLETEDAssessment of Hypertensive Retinopathy Using Neural Network "RetinAIcheck"NCT07471971 · lead sponsor · 2021-03-11
COMPLETEDSodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome PreventionNCT04778787 · lead sponsor · 2021-01-01
COMPLETEDLong-tErm Effects of Enhanced eXternal CountErpuLsationNCT05913778 · lead sponsor · 2020-12-10
COMPLETEDProspective Comparison of the Four Biopsy Methods for Prostate Cancer DetectionNCT05589558 · lead sponsor · 2020-10-01
COMPLETEDMicophenolate Mofetil Versus Azathioprine in MyocarditisNCT05237323 · lead sponsor · 2020-10-01
COMPLETEDEnergy Supply in Athletes and Untrained Persons With Bronchopulmonary DiseasesNCT04415827 · lead sponsor · 2020-05-23
UNKNOWNEfficacy and Safety Assessment of IRE of Localized Prostate CancerNCT04192890 · lead sponsor · 2020-01-27
UNKNOWNPulse Wave Parameters in the Assessment of Systolic Function of the Left Ventricle.NCT04788342 · lead sponsor · 2019-12-01
COMPLETEDDetermination of Diastolic Dysfunction by Single Lead ElectrocardiogramNCT04474639 · lead sponsor · 2019-09-01
COMPLETEDImprovement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative ConversationsNCT04506710 · lead sponsor · 2019-08-01
UNKNOWNNeuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot StudyNCT04391491 · lead sponsor · 2019-03-01
COMPLETEDEfficacy and Safety Assessment of IRE of Localized Prostate Cancer.NCT03504995 · lead sponsor · 2018-04-19
COMPLETEDImpact of Platinum-based Cancer Treatment on Endothelial FunctionNCT04681560 · lead sponsor · 2018-01-18
COMPLETEDSURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart FailureNCT07631780 · collaborator · 2026-06-01
NOT_YET_RECRUITINGNeoadjuvant Chemotherapy in Breast CancerNCT04802941 · collaborator · 2021-03-12
UNKNOWNPersonalized Evidence-based Treatment in Patients With Invasive Breast CancerNCT04798976 · collaborator · 2021-03-01
UNKNOWNAntihypertensive Therapy in Patients With ComorbiditiesNCT04791046 · collaborator · 2021-02-01
UNKNOWNDrugs studied in this sponsor's trials
3 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing I.M. Sechenov First Moscow State Medical University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
colchicine1
furosemide1
rifaximin1
Sponsor roles
lead sponsor30
collaborator4
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.